A randomized pilot study of L-arginine infusion in severe falciparum malaria: preliminary safety, efficacy and pharmacokinetics.
<h4>Background</h4>Decreased nitric oxide (NO) and hypoargininemia are associated with severe falciparum malaria and may contribute to severe disease. Intravenous L-arginine increases endothelial NO in moderately-severe malaria (MSM) without adverse effects. The safety, efficacy and phar...
Saved in:
| Main Authors: | Tsin W Yeo, Daniel A Lampah, Indri Rooslamiati, Retno Gitawati, Emiliana Tjitra, Enny Kenangalem, Ric N Price, Stephen B Duffull, Nicholas M Anstey |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0069587 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome.
by: Tsin W Yeo, et al.
Published: (2010-04-01) -
Impaired systemic tetrahydrobiopterin bioavailability and increased dihydrobiopterin in adult falciparum malaria: association with disease severity, impaired microvascular function and increased endothelial activation.
by: Tsin W Yeo, et al.
Published: (2015-03-01) -
Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia.
by: Daniel A Lampah, et al.
Published: (2011-06-01) -
L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.
by: Anna P Ralph, et al.
Published: (2013-01-01) -
Improving case definitions for severe malaria.
by: Nicholas M Anstey, et al.
Published: (2007-08-01)